WealthCollab’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
WealthCollab's PBYI Position: Q3 2026 in Review
WealthCollab held its Puma Biotechnology (PBYI) position steady in Q3 2026 at 950 shares worth $9.43K. The position accounts for ﹤0.01% of the portfolio, ranked #630.
WealthCollab first reported a position in PBYI in Q1 2025 and has held it in 7 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- WealthCollab held 950 shares of Puma Biotechnology worth $9.43K as of Q3 2026.
- WealthCollab left its Puma Biotechnology share count unchanged in Q3 2026.
- Puma Biotechnology made up ﹤0.01% of WealthCollab's portfolio in Q3 2026, its #630 holding.
- WealthCollab first reported a position in Puma Biotechnology in Q1 2025 and has held it in 7 quarters since.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on WealthCollab's 13F filing for Q3 2026, filed 12 Nov 2026.